Moore Capital Management’s GoodRx Holdings GDRX Stock Holding History

Moore Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Sell	864,044 -665,371	-44%	-$1.69M	0.04%	364
2026 Q1	$3M	Buy	1,529,415 +590,851	+63%	+$1.39M	0.06%	224
2025 Q4	$2.54M	Buy	938,564 +414,513	+79%	+$1.36M	0.04%	344
2025 Q3	$2.22M	Buy	+524,051	New	+$2.3M	0.03%	346
2025 Q1	–	Sell	-237,892	Closed	-$1.11M	–	539
2024 Q4	$1.11M	Buy	+237,892	New	+$1.31M	0.01%	366

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Moore Capital Management's GDRX Position: Q2 2026 in Review

Moore Capital Management reduced its GoodRx Holdings (GDRX) stake by 44% in Q2 2026, selling an estimated $1.69M and leaving 864,044 shares worth $2.49M. The position accounts for 0.04% of the portfolio, ranked #364.

Moore Capital Management first reported a position in GDRX in Q4 2024 and has held it in 5 quarters since. The position peaked at $3M in Q1 2026. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Moore Capital Management held 864,044 shares of GoodRx Holdings worth $2.49M as of Q2 2026.
Moore Capital Management sold 665,371 GoodRx Holdings shares in Q2 2026, an estimated $1.69M.
GoodRx Holdings made up 0.04% of Moore Capital Management's portfolio in Q2 2026, its #364 holding.
Moore Capital Management first reported a position in GoodRx Holdings in Q4 2024 and has held it in 5 quarters since.
Moore Capital Management's GoodRx Holdings position peaked at $3M in Q1 2026.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.